XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 5,675,274 $ 4,818,849 $ 16,572,323 $ 14,067,301
Cost of goods sold 3,695,607 3,108,082 10,805,910 9,126,614
Gross profit 1,979,667 1,710,767 5,766,413 4,940,687
Operating expenses:        
Selling, administrative and other expenses 1,458,418 1,338,768 4,226,412 3,883,241
Depreciation and amortization 86,563 72,121 259,822 218,377
Provision for doubtful accounts 6,146 4,284 13,539 14,230
Total operating expenses 1,551,127 1,415,173 4,499,773 4,115,848
Non-operating expense (income):        
Interest expense, net 18,220 14,167 58,318 47,853
Other (7,616) (17,547) (26,897) (77,454)
Total non-operating expense (income) 10,604 (3,380) 31,421 (29,601)
Income before income taxes 417,936 298,974 1,235,219 854,440
Income taxes 105,578 70,389 304,494 211,649
Net income $ 312,358 $ 228,585 $ 930,725 $ 642,791
Dividends declared per common share (usd per share) $ 0.8950 $ 0.8150 $ 2.6850 $ 2.445
Basic earnings per share (usd per share) 2.21 1.60 6.57 4.47
Diluted earnings per share (usd per share) $ 2.20 $ 1.59 $ 6.53 $ 4.44
Weighted average common shares outstanding (in shares) 141,336 142,871 141,609 143,826
Dilutive effect of stock options and non-vested restricted stock awards (in shares) 773 718 819 796
Weighted average common shares outstanding - assuming dilution (in shares) 142,109 143,589 142,428 144,622